Table 1.
The current regimens for H. pylori treatment.
Therapy | Components (usual Doses and Frequencies) | Days (n) | Reference |
---|---|---|---|
Clarithromycin triple therapy | Clarithromycin (500 mg bid)+amoxicillin (1 g bid) or metronidazole (500 mg bid)+PPI (standard dose bid) | 14 | 47 |
Bismuth quadruple | Bismuth (300 mg qid)+metronidazole (500 mg tid or qid)+tetracycline (500 mg qid)+PPI (standard dose bid) | 10 or 14 | 47 |
Levofloxacin triple | Levofloxacin (500 mg qd)+ amoxicillin (1 g bid)+ PPI (standard dose bid) | 14 | 12 |
Levofloxacin quad | Levofloxacin (500 mg qd)+ PPI (standard dose bid)+ 2 antibiotics (multiple variations exist) | 10 or 14 | 2 |
Concomitant therapy | Clarithromycin (500 mg bid)+ amoxicillin (1 g bid)+metronidazole or tinidazole (500 mg bid)+PPI (standard dose bid) | 14 | 12 |
Sequential therapy | PPI (high-dose* qd) + amoxicillin (1 g bid); then PPI (standard dose bid)+ clarithromycin (500 mg bid)+nitroimidazole (500 mg bid) | 5–7 then 5–7 | 12 |
Rifabutin triple | Rifabutin (150 or 300 mg qd), amoxicillin (1 g bid), PPI (standard dose bid) | 10 or 14 | 47 |
High-dose dual | Amoxicillin (2 − 3 g daily in 3–4 split doses) PPI (high-dose* bid) | 14 | 47 |
Vonoprazan dual therapy | Vonoprazan (20 mg bid)+amoxicillin (750 mg bid) | 7 | 48 |
Vonoprazan triple therapy | Vonoprazan (20 mg bid) + amoxicillin (750 mg bid) + clarithromycin (200 mg bid) | 7 | 48 |
*PPI standard dose is as follows: pantoprazole 40 mg, esomeprazole 20 mg, omeprazole 20 mg, lansoprazole 30 mg, rabeprazole 20 mg.dexlansoprazole 30 mg, “High-dose” implies double the standard dose; qd: once daily; bid: twice daily; tid: thirce daily; qid: four times daily